Corneal bioprinting utilizing collagen‐based bioinks and primary human keratocytes

Journal of Biomedical Materials Research - Part A - Tập 107 Số 9 - Trang 1945-1953 - 2019
Daniela F. Duarte Campos1, Malena Rohde2, M. Ross3,1, Pasha Anvari1, Andreas Blaeser1,4, Michael Vogt5, Claudia Panfil6, Gary Hin‐Fai Yam7, Jodhbir S. Mehta8,7, Horst Fischer1, Peter Walter2, Matthias Fuest2
1Department of Dental Materials and Biomaterials Research, RWTH Aachen University Hospital, Aachen, Germany
2Department of Ophthalmology, RWTH Aachen University Hospital, Aachen, Germany
3Department of Chemical Engineering, McMaster University, Hamilton, Canada
4Medical Textiles and Biofabrication, Institute for Textile Technology (ITA), RWTH Aachen University, Aachen, Germany
5Interdisciplinary Center for Clinical Research IZKF, RWTH Aachen University Hospital, Aachen, Germany
6Aachen Center for Technology Transfer in Ophthalmology (ACTO), Aachen, Germany
7Tissue Engineering and Stem Cell Group, Singapore Eye Research Institute, Singapore, Singapore
8Singapore National Eye Centre, Singapore, Singapore

Tóm tắt

AbstractCorneal transplantation is the treatment of choice for patients with advanced corneal diseases. However, the outcome may be affected by graft rejection, high associated costs, surgical expertise, and most importantly the worldwide donor shortage. In recent years, bioprinting has emerged as an alternative method for fabricating tissue equivalents using autologous cells with architecture resembling the native tissue. In this study, we propose a freeform and cell‐friendly drop‐on‐demand bioprinting strategy for creating corneal stromal 3D models as suitable implants. Corneal stromal keratocytes (CSK) were bioprinted in collagen‐based bioinks as 3D biomimetic models and the geometrical outcome as well as the functionality of the bioprinted specimens were evaluated after in vitro culture. We showed that our bioprinting method is feasible to fabricate translucent corneal stromal equivalents with optical properties similar to native corneal stromal tissue, as proved by optical coherence tomography. Moreover, the bioprinted CSK were viable after the bioprinting process and maintained their native keratocyte phenotypes after 7 days in in vitro culture, as shown by immunocytochemistry. The proposed bioprinted human 3D corneal models can potentially be used clinically for patients with corneal stromal diseases.

Từ khóa


Tài liệu tham khảo

10.1167/iovs.05-1647

10.1016/j.exer.2012.06.009

10.1002/adhm.201800894

10.1016/j.cobme.2017.04.003

10.1002/adhm.201500677

10.1007/s10856-016-5763-9

10.1177/039139880302600810

10.1016/j.biomaterials.2006.04.022

10.1002/adhm.201501033

10.1089/ten.tea.2014.0231

10.1126/scitranslmed.3001022

10.1016/j.biomaterials.2013.11.079

10.1016/j.ophtha.2006.06.047

10.2217/rme-2016-0054

10.1001/jamaophthalmol.2015.4776

10.1155/2014/724546

10.1159/000028064

10.1089/ten.teb.2014.0397

10.1016/j.exer.2018.05.010

10.1056/NEJMoa1712770

10.1089/ten.tea.2014.0562

10.1177/2041731418769863

10.1016/j.actbio.2018.01.023

10.1136/bjo.85.4.437

10.1088/1758-5082/5/2/025008

10.1089/107632700418038

10.1056/NEJMoa0905955

10.1136/bjophthalmol-2011-301164

10.1016/j.biomaterials.2018.04.034

10.1007/s10856-012-4848-3

10.1089/ten.tea.2012.0545

10.3727/096368914X685069

Thông tin
Thông tin xuất bản

Journal of Biomedical Materials Research - Part A

Tập 107 Số 9

1945-1953

Thông tin tác giả